Search
for
Sort by
Research 481–510 of 1000+
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Risk factors associated with development and persistence of long COVID
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Smart Diagnostic System for Health Risk Assessment
- Risk profile of non-cicatricial alopecia in females
- Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis
- Anabolic-androgenic steroids and cardiovascular risk
- Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Spironolactone May Reduce the Risk of Incident Rosacea
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Low serum testosterone is associated with an increased risk of first-time renal calculi in men without testosterone replacement therapy
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome